AGRN and pachyonychia congenita: In addition, researchers found that circulating agrin + extracellular vesicles (EVs) can be used as specific and sensitive biomarkers of disease progression in patients with PC, who did not undergo surgery, through the ROC curve analysis, and combination with CD133 + EVs improves the accuracy of disease progression prediction [186].